Evidence map›Paper›PMID 34325732›Full record

ReviewItalian journal of pediatrics2021

Disease burden and quality of life of in children with sickle cell disease in Italy: time to be considered a priority.

Raffaella Colombatti, Maddalena Casale, Giovanna Russo

Open access · goldAbstract readLetterReview
In one paragraph

Review in Italian journal of pediatrics, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed, 1 pooled it
1.7field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 1 synthesis or guideline pooled it, 22 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Raffaella ColombattiClinic of Pediatric Hematology Oncology, Department of Woman's and Child's Health, University of Padova, Padova, Italy.ORCID https://orcid.org/0000-0001-9797-0457
Maddalena CasaleDepartment of Women, Child and General and Specialized Surgery, University "Luigi Vanvitelli", Naples, Italy.ORCID https://orcid.org/0000-0003-4740-2421
Giovanna RussoPediatric Hemato-Oncology Unit, Department of Clinical and Experimental Medicine, University of Catania, Catania, Italy. diberuss@unict.it.ORCID http://orcid.org/0000-0001-9369-7473
University of Catania · ITUniversity of Padua · IT

Funding

Assessorato Regionale della Salute, Regione Siciliana Progetto Obiettivo PSN Anno 2016
6 · The paper itself

Abstract

The objective of the present article is to highlight the need for attention to Quality of Life of patients with Sickle Cell Disease living in Italy. The transformation of sickle cell disease from a severe life-threatening disease of childhood into a chronic, lifelong condition due to the significant improvements in care and treatment options, imposes increasing new challenges to health care providers and patients. Patients now face physical, psychosocial and emotional challenges throughout their lives. They generally have to receive chronic treatments and regular multidisciplinary monitoring which increase social and emotional burden rendering adherence to treatment sometimes complicated. A chronic disease impacts all aspects of patients' lives, not only the physical one, but also the social and emotional aspects as well as the educational and working life. The entire "Quality of Life" is affected and recent evidence demonstrates the importance quality of life has for patients with chronic illness. The results of this review focus on emerging data regarding quality of life across the lifespan of patients with Sickle Cell Disease, and highlight the need for more action in this field in Italy, where recent immigration and improved care determine an increasing population of children with sickle cell disease being taken into long term care.

Indexed as

Cost of IllnessQuality of LifeAnemia, Sickle CellChildHumansItalyAdolescentChildDisease burdenItalyQuality of lifeSickle cell disease

Identifiers

PMID34325732
PMCPMC8323323
OpenAlexW3184165727

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.